How do we impress upon women that they need to prioritize their own health before providing for the people who need them? A ...

Eli Lilly and Sangamo Therapeutics have entered into a licensing agreement worth over $1.4bn to deliver genomic medicines for ...

Ipsen has announced that its Iqirvo (elafibranor) tablets have been accepted by the Scottish Medicines Consortium (SMC) to ...

Researchers from the University of Birmingham (UoB) and the University of Naples Federico II have found that a sequence of ...

Clear health communication has never been more critical, as shown by the 2025 surge in ADHD self-diagnoses in the UK, driven ...

GSK and ABL Bio have entered into an agreement worth over £2bn to develop new drugs for neurodegenerative diseases.

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab)-based perioperative regimen has been approved by the European ...

Johnson & Johnson (J&J) has announced that Stelara (ustekinumab) has been approved by the European Commission (EC) to treat ...

The world of pharmaceutical brand planning as we know it is evolving rapidly. Artificial intelligence (AI) is creating new ...

Mednet, a digital marketing and brand partner in Pharma, has recently strengthened its partnership with women’s charity Smart Works Leeds by donating fully-wiped and refurbished laptops to support the ...

Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat ...

Amgen’s Uplizna (inebilizumab-cdon) has been approved by the US Food and Drug Administration (FDA) as the first treatment for ...